Nan van Geloven on Platelet Transfusion Outcomes in Preterm Infants With Severe Thrombocytopenia
Nan van Geloven, Assistant Professor at Leiden University Medical Center, reposted from JAMA on LinkedIn:
”NEW PAPER
“Regular predictions are not suited for supporting individual treatment decisions. Combining prediction with causal inference is needed instead.”
Telling is one thing, doing is another.
In this new JAMA paper we put our money where our mouth is and applied causal inference to develop and evaluate a prediction model that estimates risks under different treatment options, supporting treatment decisions in preterm infants.
Highly rewarding to get the chance to put our newly developed methods in action, together with a great team of clinicians and epidemiologists.”
JAMA shared on LinkedIn:
”Among preterm infants with severe thrombocytopenia, this modeling study found substantial variation among individuals in predicted benefits and harms of prophylactic platelet transfusion based on their current clinical characteristics.”
Read the full article in JAMA.
Article: Individualized Prediction of Platelet Transfusion Outcomes in Preterm Infants With Severe Thrombocytopenia
Authors: Hilde van der Staaij, Ilaria Prosepe, Camila Caram-Deelder, Ruth H. Keogh, Emöke Deschmann, Christof Dame, Wes Onland, Sandra A. Prins, Florian Cassel, Esther J. d’Haens, Elke van Westering-Kroon, Peter Andriessen, Sabine L. Vrancken, Christian V. Hulzebos, Daniel C. Vijlbrief, Suzanne F. Fustolo-Gunnink, Karin Fijnvandraat, Enrico Lopriore, Johanna G. van der Bom, Nan van Geloven
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp